287410 — Jeisys Medical Income Statement
0.000.00%
Last trade - 00:00
- KR₩712bn
- KR₩690bn
- KR₩143bn
- 98
- 19
- 37
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 81,296 | 116,550 | 143,030 |
Cost of Revenue | |||||
Gross Profit | — | — | 56,647 | 79,575 | 98,970 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 53.5 | 102 | 57,692 | 82,514 | 106,716 |
Operating Profit | -53.5 | -102 | 23,604 | 34,035 | 36,314 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 46.7 | -28.4 | 13,093 | 33,886 | 35,498 |
Provision for Income Taxes | |||||
Net Income After Taxes | 39.6 | -21.2 | 13,761 | 27,012 | 25,108 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 39.6 | -21.2 | 13,592 | 27,130 | 24,800 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 39.6 | -21.2 | 13,592 | 28,393 | 24,941 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.35 | -5.01 | 180 | 371 | 322 |
Dividends per Share |